Lung Cancer Clinical Trial
Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR)
Summary
A research study of a procedure to treating lung cancer with focused radiation called Stereotactic Ablative Radiotherapy (SABR). The purpose of this study is to evaluate the effectiveness of individualizing the dose of radiation used to treat lung tumors with SABR based on tumor-specific factors.
While recent research has identified SABR as a promising method to increase local control (LC) of lung cancer, further research has indicated that tumor volume is a prognostic factor, with increased size/volume of tumor being associated with poorer outcomes. This study explores if a volume-adapted strategy for the radiologic exposure (dose) will improve efficacy in larger tumors (ie, > 10 cc).
This is a study of the procedure stereotactic ablative radiotherapy (SABR). It is not a study of a specific drug or device.
Eligibility Criteria
INCLUSION CRITERIA
Limited primary non-small cell lung cancers (NSCLC) (ie, graded as T1aN0M0, T1bN0M0, T2aN0M0, T2bN0M0, or T3N0M0), or metastatic lung tumors with no evidence of uncontrolled extrathoracic metastases.
Up to 4 lesions may be considered.
For a single lesion, the sum of three orthogonal diameters can be no more than 20 cm.
For multiple lesions, no lesion can have a sum of orthogonal diameters greater than 15 cm.
Both peripheral and central tumors are accepted for this trial.
Age ≥ 18 years old
Patients may be enrolled more than once (eg, for a new tumor lesion)
EXCLUSION CRITERIA
Contraindication for radiotherapy
Pregnant and breastfeeding women are excluded
If prior radiation therapy, there is no overlap with the prior high dose regions (EXCEPTION: by approval of the investigators).
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 3 Locations for this study
Stanford California, 94305, United States
Seattle Washington, 98104, United States
Toronto Ontario, ON M5, Canada
Sapporo Hokkaido, , Japan
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.